Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy.

Sottile A, Ortega C, Berruti A, Mangioni M, Saponaro S, Polo A, Prati V, Muto G, Aglietta M, Montemurro F.

Oncol Lett. 2012 Apr 1;3(4):819-824. Epub 2012 Jan 16.

PMID:
22741000
[PubMed]
Free PMC Article
2.

Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients.

Douglas TH, Morgan TO, McLeod DG, Moul JW, Murphy GP, Barren R 3rd, Sesterhenn IA, Mostofi FK.

Cancer. 1997 Jul 1;80(1):107-14.

PMID:
9210715
[PubMed - indexed for MEDLINE]
3.

Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.

Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC Jr; SEARCH Database Study Group.

J Urol. 2003 Jun;169(6):2136-41.

PMID:
12771735
[PubMed - indexed for MEDLINE]
4.

Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.

Do T, Parker RG, Do C, Tran L, Do L, Dolkar D.

Cancer J Sci Am. 1998 Sep-Oct;4(5):324-30.

PMID:
9815297
[PubMed - indexed for MEDLINE]
5.

Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.

Haese A, Graefen M, Steuber T, Becker C, Pettersson K, Piironen T, Noldus J, Huland H, Lilja H.

Prostate. 2001 Oct 1;49(2):101-9.

PMID:
11582588
[PubMed - indexed for MEDLINE]
6.

Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base.

Freedland SJ, Kane CJ, Presti JC Jr, Terris MK, Amling CL, Dorey F, Aronson WJ.

J Urol. 2003 Mar;169(3):969-73.

PMID:
12576824
[PubMed - indexed for MEDLINE]
7.

Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy.

Soergel TM, Koch MO, Foster RS, Bihrle R, Wahle G, Gardner T, Jung SH.

J Urol. 2001 Dec;166(6):2198-201.

PMID:
11696735
[PubMed - indexed for MEDLINE]
8.

Serum percent free prostate-specific antigen in metastatic prostate cancer.

Lin DW, Noteboom JL, Blumenstein BA, Ellis WJ, Lange PH, Vessella RL.

Urology. 1998 Sep;52(3):366-71.

PMID:
9730445
[PubMed - indexed for MEDLINE]
9.
10.

Percent free prostate-specific antigen values in men with recurrent prostate cancer after radical prostatectomy.

Wojno KJ, Vashi AR, Schellhammer PF, Wright GL Jr, Montie JE.

Urology. 1998 Sep;52(3):474-8.

PMID:
9730464
[PubMed - indexed for MEDLINE]
11.

Markers and meaning of primary treatment failure.

Swindle PW, Kattan MW, Scardino PT.

Urol Clin North Am. 2003 May;30(2):377-401. Review.

PMID:
12735513
[PubMed - indexed for MEDLINE]
12.

Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.

Catalona WJ, Southwick PC, Slawin KM, Partin AW, Brawer MK, Flanigan RC, Patel A, Richie JP, Walsh PC, Scardino PT, Lange PH, Gasior GH, Loveland KG, Bray KR.

Urology. 2000 Aug 1;56(2):255-60.

PMID:
10925089
[PubMed - indexed for MEDLINE]
13.

Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomy.

Brandli DW, Koch MO, Foster RS, Bihrle R, Gardner TA.

BJU Int. 2003 Jul;92(1):19-22; discussion 22-3.

PMID:
12823376
[PubMed - indexed for MEDLINE]
14.

Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigen.

Murphy GP, Barren RJ, Erickson SJ, Bowes VA, Wolfert RL, Bartsch G, Klocker H, Pointner J, Reissigl A, McLeod DG, Douglas T, Morgan T, Kenny GM, Ragde H, Boynton AL, Holmes EH.

Cancer. 1996 Aug 15;78(4):809-18. Erratum in: Cancer 1996 Oct 1;78(7):1524.

PMID:
8756376
[PubMed - indexed for MEDLINE]
15.

Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy.

Giovacchini G, Picchio M, Coradeschi E, Bettinardi V, Gianolli L, Scattoni V, Cozzarini C, Di Muzio N, Rigatti P, Fazio F, Messa C.

Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):301-9. doi: 10.1007/s00259-009-1253-3. Epub 2009 Sep 15.

PMID:
19756592
[PubMed - indexed for MEDLINE]
16.

Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy.

Freedland SJ, deGregorio F, Sacoolidge JC, Elshimali YI, Csathy GS, Dorey F, Reiter RE, Aronson WJ.

J Urol. 2003 Apr;169(4):1325-30.

PMID:
12629353
[PubMed - indexed for MEDLINE]
17.

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.

Kupelian PA, Katcher J, Levin HS, Klein EA.

Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52.

PMID:
9169811
[PubMed - indexed for MEDLINE]
18.

Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.

Bastian PJ, Palapattu GS, Yegnasubramanian S, Lin X, Rogers CG, Mangold LA, Trock B, Eisenberger M, Partin AW, Nelson WG.

Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5361-7.

PMID:
17875764
[PubMed - indexed for MEDLINE]
Free Article
19.

Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.

Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F.

Eur Urol. 2008 Jul;54(1):118-25. doi: 10.1016/j.eururo.2008.02.018. Epub 2008 Feb 26.

PMID:
18314255
[PubMed - indexed for MEDLINE]
20.

Serum half-life time determination of free and total prostate-specific antigen following radical prostatectomy--a critical assessment.

Brändle E, Hautmann O, Bachem M, Kleinschmidt K, Gottfried HW, Grünert A, Hautmann RE.

Urology. 1999 Apr;53(4):722-30.

PMID:
10197847
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk